Figure 4From: Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritisWeight lost experienced by untreated control rats ( n = 10) during the experimental period as compared to minimal change in the NM-treated rats ( n = 10). N, number; NM, nafamostat mesylate.Back to article page